Mark Lee, MD, PhD

Chief Executive Officer and Co-Founder

Dr. Lee was most recently Senior Vice President and Global Head for Personalized Healthcare, Product Development at Genentech/Roche. Prior to joining Genentech, Mark was a member of the founding leadership team and Head of Clinical Development and Medical Affairs at GRAIL, where his team built one of the largest clinical research programs in genomic medicine aimed at early cancer detection. Some of his previous roles include Lead for Oncology Clinical Sciences at Google[x] Life Sciences, Chief Medical Officer at Boreal Genomics, and Vice President of Oncology Development at Genomic Health, where he led the successful development and validation of the Oncotype DX Colon and Prostate Cancer Assays. Mark received a PhD in Biological Chemistry and Molecular Pharmacology from Harvard, and a MD from Stanford University, where he completed his internal medicine residency and medical oncology fellowship.

Christer Svedman, MD, PhD

Head of Clinical Science and Co-Founder

Christer has more than 20 years of oncology experience working in academia (Karolinska, Stockholm, Sweden),  pharma (GSK) and diagnostic development (Genomic Health).  His research includes the development of a transdermal drug delivery technique, a technique for sampling of interstitial fluid,  a prognostic gene expression assay in renal cancer, a liquid biopsy assay, abscopal effects of stereotactic radiation therapy and reports on differences in access to new cancer drugs. He has also worked extensively with the LC-SCRUM (Japanese lung cancer group) in Precision Medicine Asia,  a spin out company from the NCCHE, focussed on expanding a large clinical genomic registry in lung cancer used to screen patients for clinical trials in Japan and South-East Asia.

Dennis Cieri

Senior Technology Advisor

A Healthcare IT veteran with 40-plus years of experience, Dennis joined Syapse in 2018 as Senior Data Engineer and was SVP of Product Development prior to joining N-Power Medicine.

Dennis’ career began with a large health insurer, where he stepped up the management chain before transitioning to an entrepreneurial environment in the late 90s. He created several technology companies that sold single-focus products for the Healthcare Industry.

Before joining Syapse, as a co-founder of Gorman Member Services, Dennis and his team built the Valencia Product that reconciled enrollment and financial data for over one-half of all Affordable Care Act Members.

Dennis holds an Associate Degree in Computer Science and a Bachelor’s Degree in Finance, both from Saint Joseph’s University.

Emily Luvison

Head, Security, Privacy, Quality & Compliance

Emily is a compliance leader with oversight of cybersecurity, privacy, and quality compliance programs supporting digital health products and platforms. She was most recently the Principal Cybersecurity Compliance Lead in Digital Health Technologies at Genentech/Roche where she developed the Digital Health Technologies Compliance function and launched numerous regulated software as a medical device (SaMD) products, clinical decision support tools and digital health platforms across oncology, neurology and ophthalmology therapeutic areas. Prior to Genentech, Emily was the Head of Compliance Programs at Roche Diagnostics Information Solutions, and previously served as Senior Security Risk Assurance Consultant to Ernst & Young LLP. Emily is a Certified Information Systems Auditor and was previously a HITRUST CSF Practitioner.

Jess Sinir

Head of Program Management

Luke Peterson

Head, Network Business Development

Luke is a passionate healthcare technologist who thrives working elbow to elbow with healthcare providers and health systems at the intersection of people, processes, data, and technology in clinical and research use cases.  He started his career at Epic implementing physician ordering and documentation modules across specialties plus structured order-results interfaces with ancillary systems.  Luke was most recently at Syapse, where he led all things health systems partnering with oncology, research and technology teams to harmonize and harness the power of real world clinical genomic data to support research and clinical care. At N- Power Medicine, Luke continues the mission of bringing the culture of research to community health systems, oncologists, and patients.

Maria Ferrari

Chief of Staff  and Head of Integration

Maria has over 15 years of industry experience in operations and process development. Most recently, Maria was a Senior Product Manager at Roche leading a cross-functional ctDNA Product Core Team responsible for developing a next generation liquid biopsy assay to detect early recurrence of cancer.

Prior to this, Maria was a founding member at GRAIL, leading the build-out and management of one of the largest biobanks of research clinical samples from GRAIL’s CCGA and STRIVE observational studies. Maria spent 12 years at Google in the Ads and engineering organization and was an early member of Google Life Sciences /Verily where she helped develop its clinical program and enroll the first 100 patients into Project Baseline Health Study. 

Michael Seiden, MD

Chief Medical Officer and Head of Network Services

Michael is a distinguished leader in oncology care and research in both the academic and community settings, most recently serving as President of the US Oncology Network, and previously, CEO and President of Fox Chase Cancer Center.  Earlier in his career, Michael served as Chief of Clinical and Translational Cancer Research at MGH.

Ruchika Kumar

General Counsel and Head of People

Ruchika has over 20 years of experience in the healthcare industry providing advice and counsel on biotech/pharmaceutical regulation & compliance, digital health, market access, privacy and clinical trial innovation. She is an experienced lawyer with a demonstrated history of working successfully in the biotechnology industry. Prior to joining N-Power Medicine as Head of Legal, Ruchika spent 17 years at Genentech-Roche and most recently was the Associate General Counsel there. She is a member of the New York Bar and California Bar. She serves on the board of Muso Health and OpenBiome. She has studied at premiere institutions both in India and the US and has a postgraduate degree from the University of Pennsylvania – Law School.

Sydnie Reed

Senior Director, Pharma Partnering and Portfolio Management

Sydnie leads Pharma Partnering and Portfolio Management at N-Power Medicine. Prior to joining N-Power, she held various roles in clinical development, commercial, strategy and business development at J&J and Pfizer in Japan and China and, most recently, led Portfolio Management for the Oncology TA at Roche Genentech. With a commitment to enabling equitable access to therapies across geographies and demographic groups, she recognizes the fundamental challenge in achieving this lies in broad access to clinical trials and is passionate about bringing these opportunities to more oncologists and patients around the world.

Thomas Bengtsson, PhD

Head, Data and Technology

Thomas is a Data Science leader with over 12 years of pharmaceutical industry experience. Thomas spent 13 years at Roche/Genentech in Biostatistics. Most recently he served as Senior Director and Global Head for Imaging-Data Science at Roche’s Personalized Healthcare, Product Development organization where he led a team working to enable large-scale image analysis across oncology and develop tools to automate response assessment based on longitudinal CT- and FDG-PET scans. Prior to Roche, Thomas was a member of the Technical Staff at Bell Laboratories. He received his PhD in Statistics from the University of Missouri-Columbia.

Will Chen

Senior Director, Pharma Alliance Management

Will is a geneticist by training, with over 15 years of experience working with the pharmaceutical industry on the use of data to address research and business questions. In addition to his scientific background, Will has led strategic business and commercial projects for the top large and specialty pharmaceutical industry companies as a management consultant with McKinsey & Co. Prior to joining Syapse, Will led the creation of Elsevier’s Precision Medicine team including the development of new product offerings leveraging big data. Will has a PhD in Genetics from Stanford University School of Medicine and B.S. in biology from Massachusetts Institute of Technology.